Dissimilar effects of prostacyclin, prostaglandin E1, and prostaglandin E2 on myocardial infarct size after coronary occlusion in conscious dogs.
D000818:Animals; D001157:Arterial Occlusive Diseases / Q000150:complications* / Q000401:mortality; D003331:Coronary Vessels / Q000503:physiopathology; D004285:Dogs; D004562:Electrocardiography; D011464:Epoprostenol / Q000494:pharmacology*; D006439:Hemodynamics; D009203:Myocardial Infarction / Q000150:complications / Q000473:pathology / Q000503:physiopathology*; D011453:Prostaglandins / Q000494:pharmacology*; D011458:Prostaglandins E / Q000494:pharmacology*; D012039:Regional Blood Flow; D014693:Ventricular Fibrillation / Q000150:complications
D011453:Prostaglandins; D011458:Prostaglandins E; D011464:Epoprostenol